To conclude, in addition to lifestyle changes, such as physical activity and dietary modifications as important adjuncts to pharmacotherapy in managing NAFLD, GLP1-RAs demonstrated the highly efficient modulation and alleviation of hepatic steatosis and aberrant signaling pathways involved in NAFLD pathophysiology and progression in vitro. This evidence concerns the gene GLP1R and Hepatic steatosis.